Relationship between cholesterol metabolism, ApoE and brain volumes in Alzheimers disease

Valerio Leoni, Claudio Caccia

Research output: Contribution to journalArticle

Abstract

APOE genotype, aging and midlife hypercholesterolemia are well-established risk factors for late-onset Alzheimers disease (AD). ApoE and cholesterol are involved in the pathogenesis of AD since they influence amyloid-β accumulation and Tau pathology. APOE ε4 carriers were found to present lower levels of amyloid-β1-42, higher tau and phosphorylated tau and a higher degree of brain atrophy at any disease stage. Presence of ApoE4 shifts the onset of the disease towards a younger age and makes progression faster. Hypercholesterolemia together with other major cardiovascular risk factors were found to be involved in the pathogenesis of AD, but reduced plasma cholesterol levels were described in demented patients. Significant correlations were found between cholesterol precursors lathosterol, lanosterol and 24S-hydroxycholesterol (a putative marker of brain cholesterol turnover) in plasma and brain atrophy as quantified by MRI. It is likely that neurodegeneration affects both brain and whole-body cholesterol metabolism in AD.

Original languageEnglish
Pages (from-to)613-626
Number of pages14
JournalFuture Neurology
Volume6
Issue number5
DOIs
Publication statusPublished - Sep 2011

    Fingerprint

Keywords

  • 27-hydroxycholesterol
  • APOE genotype
  • atrophy
  • biomarker
  • cerebrovascular risk factor
  • mild cognitive impairment
  • MRI
  • oxysterol

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this